Net Cash Provided by (Used in) Financing Activities of Augmedix, Inc. from 31 Dec 2018 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Augmedix, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2018 to 31 Mar 2024.
  • Augmedix, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $59,000, a 99% decline year-over-year.
  • Augmedix, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $43,370,000.
  • Augmedix, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1,237,000, a 103% decline from 2021.
  • Augmedix, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $37,827,000, a 43% increase from 2020.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Augmedix, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $59,000 -$5,026,000 -99% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q1 2023 $5,085,000 +$5,072,000 +39015% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $13,000 -$1,809,000 -99% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $1,822,000 +$1,324,372 +266% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q1 2020 $497,628 +$486,603 +4414% 01 Jan 2020 31 Mar 2020 10-Q/A 30 Jun 2021 2021 Q1
Q1 2019 $11,025 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q4 2018 $35,000 27 Dec 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY

Augmedix, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $43,370,000 +$44,607,000 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2024 2023 FY
2022 $1,237,000 -$39,064,000 -103% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
2021 $37,827,000 +$11,410,000 +43% 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023 2022 FY
2020 $26,417,000 +$9,249,222 +54% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2019 $17,167,778 01 Jan 2019 31 Dec 2019 10-K/A 30 Jun 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.